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Abstract
Nicotinamide adenine dinucleotide—reduced form (NADH):quinone oxidoreductase (respiratory Complex I), F420H2 oxidoreductase and
complex, membrane-bound NiFe-hydrogenase contain protein subunits homologous to a certain type of bona fide antiporters. In Complex I,
these polypeptides (NuoL/ND5, NuoM/ND4, NuoN/ND2) are most likely core components of the proton pumping mechanism, and it is thus
important to learn more about their structure and function. In this work, we have determined the transmembrane topology of one such
polypeptide, and built a 2D structural model of the protein valid for all the homologous polypeptides. The experimentally determined
transmembrane topology was different from that predicted by majority vote hydrophobicity analyses of members of the superfamily. A
detailed phylogenetic analysis of a large set of primary sequences shed light on the functional relatedness of these polypeptides.
D 2002 Elsevier Science B.V. All rights reserved.
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1. Introduction
Nicotinamide adenine dinucleotide—reduced form
(NADH):quinone oxidoreductase or Complex I, is the
largest, most complex and least understood of the respira-
tory chain enzymes. This membrane-bound, multisubunit
enzyme catalyzes the oxidation of NADH to NAD+ and
donates electrons to the quinone pool. In this reaction, a
flavin mononucleotide and six to eight iron–sulfur clusters
serve as intrinsic redox components. In bacteria, Complex I
generally contains 14 different subunits, of which 7 are
located in the promontory part of the complex, facing the
cytoplasm, whereas the remaining polypeptides (NuoA, H,
J, K, L, M and N) are very hydrophobic and form the
membrane spanning part of the enzyme. The flavin and
iron–sulfur clusters are bound to subunits in the promontory
part of the enzyme. The electron transfer through the
mitochondrial enzyme is coupled to proton translocation
across the membrane with a stoichiometry of 4 H+/2e [1].
In addition, the enzyme is capable of DAH+ -supported NAD+
reduction. Although the subject of much speculation, the
mechanism of energy transduction is not understood.
The NuoL, NuoM and NuoN subunits (Fig. 1) are
homologous protein subunits, which also show sequence
similarity to one particular type of antiporter [2]. These
polypeptides are most likely important players in the proton
translocation machinery of Complex I [3,4], and it is thus
extremely important to learn more about their structure and
function. In subfractions of mammalian Complex I, the ND5
(NuoL) and ND4 (NuoM) subunits were found close
together, but the ND2 (NuoN) subunit was found in another
subfraction [5,6]. Most recent low-resolution electron
microscopy images of Escherichia coli Complex I imply
that in one conformational state, the NuoE, F and G subunits
of the so-called NADH dehydrogenase module are also in
contact with transmembrane antiporter-like subunits [7].
An antiporter of this particular type was first discovered
in the alkalophile Bacillus halodurans C-125. The gene
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encoding the antiporter was isolated from a mutant, unable
to grow at pH 10, demonstrating that this protein was crucial
for maintaining neutral cytoplasmic pH under alkaline
growth conditions [8]. This type of bona fide antiporter
has since been found in many other alkalophile and meso-
phile bacteria, where it typically appears in a conserved
gene context or operon. In Bacillus subtilis, the operon
contains two different genes, mrpA and mrpD, encoding
polypeptides of this type, together with four genes encoding
other, unrelated antiporters and proteins that may play a role
for assembly and/or stability of the other polypeptides [9]. A
seventh protein encoded by this operon, MrpF, is a Na+-
cholate efflux protein. Both MrpA and MrpD have been
shown to have a role in Na+ resistance and Na+-dependent
pH homeostasis in B. subtilis [9–11]. When expressed in E.
coli, the Mrp antiporter was less active, but more proto-
nophore resistant than NhaA, a classical E. coli secondary
antiporter [12]. The mrp equivalent operon in Staphylococ-
cus aureus, named mnh, conferred Na+ resistance when
expressed in E. coli [13]. In Rhizobium meliloti, the MrpA
corresponding protein, PhaA, was demonstrated to be a K+/
H+ antiporter [14]. It remains to be established whether the
proteins encoded by the operon form a multisubunit com-
plex or if they function individually in monomeric or
multimeric form (see Fig. 1).
In addition, in Complex I and Complex I-like enzymes
such as chloroplast NADPH dehydrogenase and archeal
F420H2 oxidoreductase, similar antiporter-like subunits are
found in the membrane-bound complex NiFe-hydrogenases
(hydrogenase-3 and hydrogenase-4) [15]. The physiological
function of these hydrogenases is production of H2, in a
non-energy-conserving manner that maintains intracellular
pH and redox potential [16]. These hydrogenases are
composed of subunits homologous to the Complex I sub-
units NuoB, C, D, I, and H and can seemingly contain one,
two or three antiporter-like proteins (Fig. 1). A plausible
evolution of Complex I and Complex I-like enzymes from
the membrane-bound complex NiFe-hydrogenases is
described by Friedrich and Scheide [17].
In addition, we have found gene clusters containing a
gene encoding a homologous antiporter-like polypeptide
and a gene encoding a large hydrophilic protein of unknown
function in the genomes of B. subtilis (accession number
BG10949, BG12707), Vibrio cholerae (accession number
VC1581, VC1582) and Aquifex aeolicus (accession number
AA0689, AA0690), indicating that a homologous anti-
porter-like polypeptide might also play a role in a yet
unidentified enzyme complex.
There is a small but growing set of studies that indicates
that Na+ or K+ may be directly involved in the catalytic
mechanism of both Complex I [18–20] and the complex,
membrane-bound NiFe-hydrogenase [21]. It is thus possible
that the antiporter-like subunits in these enzymes are not
simply providing means for proton translocation but may
still retain a true antiporter function, or the capability to
translocate Na+ or K+ as well as H+.
Unfortunately, very little is known regarding the structure
and functional mechanism of this type of antiporter, and
Fig. 1. (A) Schematic outline of respiratory Complex I from bacteria that contains 14 protein subunits (mitochondrial Complex I contains up to 29 additional
subunits). The Complex I-like enzymes, NADPH dehydrogenase from chloroplasts and cyanobacteria and the F420H2 oxidoreductase from archea, lack the
NuoE, F and G subunits and instead contain different electron input modules. The subunit nomenclature is unfortunately not uniform. The antiporter-like
subunits are called NuoL, NuoM, NuoN or NQO12, NQO13, NQO14 in bacterial Complex I, ND5, ND4, ND2 in animal and fungi mitochondria, NAD5,
NAD4, NAD2 in plant mitochondria, NdhF, NdhD, NdhB in chloroplasts and cyanobacteria and FpoL, FpoM, FpoN in the archeal enzyme. (B) Schematic
outline of membrane-bound, complex NiFe-hydrogenase, which probably can come in variants containing one, two or three antiporter-like polypeptides.
However, the actual subunit stoichiometry in the enzyme complexes has not been determined. Note that some NiFe-hydrogenases may function without
interaction with quinone or quinone-like substrates [24,54]. The NiFe-hydrogenase module is also outlined in the Complex I enzyme, and Complex I
polypeptide names have been used for clarity. Examples of antiporter-like polypeptides in NiFe-hydrogenases are EchA, HycC, CooM, HyfB, HyfD and HyfF.
(C) Schematic outline of a bona fide antiporter. It is not known if a single polypeptide forms a functional antiporter, or if multimers are used. Again, the subunit
nomenclature is not uniform, and the MrpA-type antiporter can also be called ShaA, YufT, PhaA or MnhA, whereas the MrpD-type antiporter can be referred to
as ShaD, YufD, PhaD, or MnhD.
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even less about the homologous polypeptides in the multi-
subunit enzyme complexes. In this work, we have exper-
imentally determined the transmembrane topology of the
NuoL subunit from Rhodobacter capsulatus Complex I
using the alkaline phosphatase (PhoA) fusion protein tech-
nique developed by Manoil and Beckwith [22], and have
constructed a 2D model of the polypeptide that is valid for
all these antiporter and antiporter-like proteins. We have
also undertaken phylogenetic analyses of the proteins, from
which some pertinent indications regarding the function of
the polypeptides can be deduced.
2. Materials and methods
2.1. Growth of bacteria
Bacterial strains and plasmids used are listed in Table 1.
E. coli cells were grown aerobically at 37 jC at 200 rpm in
Luria broth medium [23], containing ampicillin (100 Ag/ml,
Duchefa) when applicable, or kept on Luria broth agar
plates (1.5% agar) with the same ampicillin concentration.
R. capsulatus were grown as E. coli but in MPYE medium
containing 0.3% peptone, 0.3% yeast extract, 1.6 mM CaCl2
and 1 mM MgCl2. E. coli transformants expressing fusion
protein were plated on Luria broth agar plates containing
ampicillin 100 Ag/ml, 5-bromo-4chloro-3-indolyl-phosphate
(X-phosphate, Duchefa) 40 Ag/ml and isopropyl-thio-h-D-
galactoside (IPTG, Saveen) 15 Ag/ml.
2.2. Standard molecular biology techniques
Cloning and subcloning was done using standard
recombinant DNA procedures as described in Sambrook et
al. [23]. Restriction enzymes were from Boehringer Man-
nheim, Promega or New England BioLabs (NEBL) and
dNTPs were from Promega or NEBL. DNA fragments and
opened vectors were purified from agarose gel with Jet Sorb
Gel extraction Kit (Genomed). DNA ligations were per-
formed at 16 jC overnight or at 4 jC for 60 h using T4
DNA ligase from NEBL or Gibco Invitrogen. E. coli cells
were transformed by electroporation using a BioRad E. coli
Pulserk transformation apparatus and electroporation cuv-
ettes from VWR International. Electrocompetent cells were
Table 1
Bacteria, plasmids and primers used in this work
Bacteria/plasmid Relevant properties Reference or source
R. capsulatus
ATCC 17015
wild type, (type strain) DSMZ, Braunschweig,
Germany
E. coli XL1-Blue recA1, endA1, gyrA96, thi, hsdR17,
supE44, relA1 (lac)
Promega
E. coli CC118 araD139 D(ara,leu)7697 DlacX74




pNuoL2 nuoL, ampR this work
pPHOA phoAV, ampR [24]
pNLF1–17 phoAV, ampR this work
Primersa Primer sequence
SacINuoL 5V-GGA GCT CAA CGT GAT GAA GGG GTA AGG-3V
NuoLPstI 5V-GGG CTG CAG ATG GAG AGG AGG TTT TGC-3V
NLF1 5V-CGC CCC CTT TTC CGT GAT CAG C-3V
NLF2 5V-GAG CGC CCC CGA ACG GAT CC-3V
NLF3 5V-GGT CAG CCG GTC AAG CCG GAT CC-3V
NLF4 5V-GAA CCG CGC CTT GTA GGC CTC G-3V
NLF5 5V-CAG CAG ATA GGA AGC GAC CCC CAC-3V
NLF6 5V-GCG GTT GAC GAC AAA GGC CTT GAT C-3V
NLF7 5V-GAG GAA ATGCAG CTC GGT CTT CGC C-3V
NLF8 5V-GGC GTC GGG CAG CCA GGT GTG-3V
NLF9 5V-GAC CAT CAT CTT GGC TTC CGG CGC-3V
NLF10 5V-CGA ATA GGC GAT CAC GCG CTT G-3V
NLF11 5V-CGC CTT GAA GAA GGC ATG CGT CAG C-3V
NLF12 5V-CGC CTT GAA GAA GGC ATG CGT CAG C-3V
NLF13 5V-GGG GAT CTT CTT GCG CAG GCC-3V
NLF14 5V-GAT GAT CGC GTC TTT CGA GAG ATA GCC-3V
NLF15 5V-GTC ATG CTT GTG ATG ATC GCC CCG C-3V
NLF16 5V-GAC ATG GCC CTC GGT CGC GTG TTC-3V
NLF17 5V-GCC CAG CAC CAT CGC AAA CGC-3V
Fusseq 5V-TTT TGC AGG TTT ATC GCT A-3V
a Primers were synthesized by the Biomolecular Recourse Facility, Lund University, Sweden, TAG Copenhagen, Denmark and MWG Biotech, Germany.
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grown in Luria broth until A600 = 0.6–0.7 and washed twice
in 10% glycerol. The final pellet was resuspended in an
equal amount of 10% glycerol and frozen in portions of 50
Al at  80 jC. DNA sequencing was performed using Big
Dyek and sequencing by the Sanger method (Applied
Biosystems) at the Biomolecular Recourse Facility, Lund
University. Small-scale boil preparations of plasmids were
done as described in Ref. [23], but using a buffer containing
8% sucrose, 5% Triton X-100, 50 mM Tris–HCl pH 8.0 and
500 Ag/ml lysozyme. When cleaner preparations were
needed, a phenol extraction step was included [23]. Large-
scale plasmid preparations were done using the Jet Star Midi
prep kit (Genomed).
2.3. Construction of pNuoL
Chromosomal DNA from R. capsulatus ATCC 17015
was prepared as described by Roth and Ha¨gerha¨ll [24], and
included an ethanol precipitation step to increase the DNA
concentration. The nuoL gene was amplified from the
chromosomal DNA by PCR using Pfu Polymerase (Stra-
tagene) and the sense primer SacINuoL and antisense primer
NuoLPstI (Table 1). The PCR was run as follows: Denatu-
ration 96 jC (3 min), 25 cycles of 96 jC denaturation (45 s),
55 jC annealing (45 s), 72 jC elongation (4 min, 2 min/
kbp) and ending with 72 jC (10 min). The resulting DNA
fragment containing NuoL and the pUC18 vector was cut
with SacI and PstI and the fragment was ligated into shrimp
PhoA treated (Boehringer Mannheim) vector. The resulting
construct was transformed into E. coli XLI Blue by electro-
poration. Small-scale plasmid preparations from transform-
ants were analyzed by BamHI digestion, that cuts four times
in the nuoL gene and resulting in fragments of 30, 33, 1794
and 2982 base pairs. Thirty-nine percent of the transform-
ants contained the correct insert. Two clones, named
pNuoL1 and pNuoL2, were kept.
2.4. Construction of fusion proteins
PCR amplification of chosen parts of nuoL was done
using VentRDNA Polymerase (NEBL) that creates blunt
end DNA fragments. PCR reactions were run using pNuoL2
as template, and sense primer SacINuoL and different
antisense primers listed in Table 1. Reactions were run with
initial denaturation 94 jC (3 min) followed by 25 cycles of
94 jC denaturation (45 s), annealing (45 s, 50–54 jC
depending on the primer pair), 72 jC elongation (1 min/
kbp). The resulting DNA fragments were digested with
SacI, that cuts in the 5V end of the fragments, before ligation
into pPhoA [24] that had been opened with SacI and SmaI.
The resulting constructs were transformed into E. coli
CC118 by electroporation. The transformants were analyzed
by EcoRI digestion of small-scale plasmid preparations or
by direct colony PCR. Individual bacterial colonies were
picked with sterile toothpicks, re-streaked on plates and the
remaining biomass was suspended in 10 Al ddH2O and
boiled for 2 min. Two microliters of the solution was used as
template in a 25-Al PCR reaction, identical to the reaction
used to create the respective fragment. A strong band of
correct size identifies a positive clone. Plasmid was isolated
from such clones using the Jet Quick Plasmid miniprep kit
(Genomed), and the correct, in frame, gene fusions were
confirmed by DNA sequencing using the Fusseq antisense
primer (Table 1, Ref. [24]).
2.5. PhoA activity measurements
Liquid cultures were inoculated with fresh bacteria from
plates and grown until A600 = 0.5–0.7. Expression of fusion
proteins was induced by addition of 1 mM IPTG and growth
was continued for 2 h. Cells were permeabilized and
assayed according to Manoil [25], using p-nitrophenyl
phosphate (Sigma Diagnostic) as substrate for PhoA.
Units of activity ¼ ½A420  ð1:75 A550Þ1000
t ðminÞ  A600  V ðmlÞ ð1Þ
Activity in units was calculated by Eq. (1), where V is the
volume of cells, and t is the time during which permeabi-
lized cells are incubated with substrate at 37 jC. A600
reflects the cell density in the solution and was measured
before substrate addition. A550 corresponds to cell debris,
and A420 monitors the yellow color development of the
substrate. A double-beam UV-150-02 spectrophotometer
(Shimadzu) or an Ultrospec 4000 UV/Visible spectropho-
tometer (Amersham Biosciences) was used for the experi-
ment.
2.6. Preparation of membrane vesicles
Membrane protein vesicles for sodium dodecyl sulfate–
polyacrylamide gel electrophoresis (SDS-PAGE) and West-
ern blot were prepared from E. coli CC118 expressing the
different fusion protein constructs, grown and induced as
described previously, except that the liquid culture was
inoculated with 1% overnight culture. The cells were
harvested by centrifugation using a Sorwall SLA 3000 rotor,
15 min at 7000 rpm, washed once in 50 mM KPO4 buffer,
pH 8.0 and stored at  20 jC. Cells were thawed at room
temperature and resuspended in 30 mM Tris–HCl pH 7.0,
10 mM KCl and phenylmethansulfonacidfluoride (Sigma-
Aldrich) was added to a final concentration of 1 mM. The
cell suspension was passed through a FrenchR Pressure cell
press (SLM-Aminco, Spectronic instruments) at 6.9 106
Pa (1000 psi). Cell debris was removed by centrifugation
using a Sorwall SS-34 rotor, 15 min and 8000 rpm, and E.
coli membranes were obtained by ultracentrifugation of the
resulting supernatant using a Beckman 50.2 Ti rotor at
45000 rpm and 1.5 h. The membranes were resuspended
in 30 mM Tris–HCl pH 7.0, 10 mM KCl using a potter,
were frozen in liquid N2 and kept at  80 jC. Protein
determination was done with the BCA Protein Assay Kit
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(Pierce) with bovine serum albumin (Sigma) as standard and
including 1% SDS. The membrane protein preparation was
repeated and analyzed twice for each fusion protein con-
struct.
2.7. Western blot
The frozen membrane protein batches were thawed at
room temperature, and DNA contamination was removed by
treatment with 10 Ag/ml DNase (Appligene) for 2 h on ice.
SDS-PAGE was done according to Scha¨gger and von Jagow
[26] using a stacking gel and 8% separating gel with
acrylamide/bis (29:1, BioRad). Samples were boiled for 5
min in loading buffer containing 4% SDS, 12% glycerol,
2% h-mercaptoethanol, 0.1% bromphenol blue, 100 mM
Tris–HCl pH 8.8. Electrophoresis was run at 120 V for 11 h
using a ProteanR II xi electrophoresis unit (BioRad). Rain-
bow markers RPN 756 (Amersham Biosciences) were used
as protein size standard. The gel was washed at room
temperature in anode buffer II to remove glycerol. The
buffer was exchanged twice during the 5-h incubation on
a rocking table.
Proteins were transferred from the gel to Immobilon P
membrane filter (Millipore) using a semi-dry blotting appa-
ratus (BioRad) as described in Ref. [27]. Anode buffer II
was used as anode buffer and the cathode buffer contained
80 mM 6-amino-n-caproicacid. The blot was run at 1.2 mA/
cm2 for 1 h and the filter was subsequently treated in
blocking buffer overnight at 4 jC. Detection with antibody
was done essentially as described in Ref. [27]. Blocking
buffer was 20 mM Tris–HCl pH 7.5, 50 mM NaCl, 0.2%
Tween 20 with 5% dry milk. The filter was washed twice in
30 ml blocking buffer without milk, and treated with
primary anti-PhoA antibodies (kindly provided by Lars
Hederstedt) at 15000 times dilution for 1 h. Filters were
washed as before and treated with PhoA-linked secondary
antibody (AKP-linked anti-rabbit Ig from goat, PharMingen,
Becton Dickinson) at 12000 times dilution for 45 min.
Finally, filters were washed four times in 30 ml blocking
buffer. Filters were developed by incubation with ECF
substrate (0.6 mg/ml, Amersham Biosciences) at 6 Ag/cm2
filter. Activities were monitored using a STORM 860
fluorimeter (Molecular Dynamics, Amersham Biosciences)
at 650 V. The SDS-PAGE gel was stained with Colloidal
Coomassie [28] after blotting to confirm that protein transfer
was successful.
2.8. Transmembrane topology prediction methods
The methods used to predict membrane spanning a-
helices were HMMTOP [29], TMHMM [30], TopPred2
[31], PHDhtm [32], TMpred [33], DAS [34], SOSUI [35–
37] and Kyte and Doolittle [38]. All methods were used
with their default values and the single-sequence mode.
HMMTOP and TMHMM both use a hidden Markov model
formalism in their predictions, TopPred2 creates a standard
hydrophobicity plot and then identifies ‘certain’ and ‘puta-
tive’ transmembrane helices. The TMpred algorithm is
based on the statistical analysis of TMbase and a database
of naturally occurring transmembrane proteins. The predic-
tion is made using a combination of several weight-matrices
for scoring. PHDhtm is based on a neural network predictor.
These five methods also predict the orientation of the
membrane protein. DAS is based on the dense alignment
surface method. The SOSUI prediction is based on the
physicochemical properties of amino acid sequences such
as hydrophobicity and charges and is developed for finding
membrane proteins in whole genome sequences.
2.9. Phylogenic analysis
Multiple alignments of the primary sequences were done
with ClustalW [39] using Phylip output format. Default
settings were: Slow pairwise alignment, Gonnet series
substitution matrix, 10.00 gap opening penalty, 0.20 gap
extension penalty, with end gap separation penalty and 8 as
gap separation penalty range. Residue specific penalties
(Pascarella gaps) that reduce or increase the gap opening
penalties at each position in the alignment or sequence were
included. Hydrophilic gaps were allowed. Thirty percent
delay divergent sequence identities and 0.5 as transition
weight (0–1) were used. The PHYLIP package [40] was
used with default settings. Phylogenic trees were made by
Prodist with a bootstrap before analysis and 100 replicates.
Prodist Neighbor computed a consensus tree by analysing
the 100 data sets with the Neighbour-Joining method. The
distances between the different polypeptides were calculated
using Genetics Computer Group software (GCG, Wisconsin
Package 10.1, Madison, WI) using distances and no correc-
tion. Consensus sequences for the individual phylogenetic
clusters (indicated in Fig. 2) were determined with a GCG
Pileup of sequences that were run through Pretty. The large
data set contained 75 primary sequences chosen to represent
all the different enzyme complexes from evolutionary dis-
tant organisms: In addition to the polypeptides listed in Fig.
5, we used the sequences of S. aureus (MnhA, accession
number Q9ZNG6, MnhD Sa, accession number Q9ZNG3),
R. capsulatus (accession number RRC00609, accession
number RRC00612), Aeropyrum pernix (SubB, accession
number B72619, SubF, accession number F72619, SubA,
accession number A72619), E. coli (NuoL, accession num-
ber P33607, NuoM, accession number P31978, NuoN,
accession number P33608), Thermus thermofilus (Nqo12,
accession number Q56227, Nqo13, accession number
Q56228, Nqu14, accession number Q56229), A. aeolicus
(NuoL, accession number O67340, NuoM, accession num-
ber O67341, NuoN, accession number O67342, NuoL,
accession number O67389, NuoM, accession number
O67390, NuoN, accession number O67391), Heliobacter
pylori (Nqo12, accession number E71839, Nqo13, acces-
sion number F71839, Nqo14, accession number G71839),
Mycobacterium tuberculosis (NuoL, accession number
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Fig. 2. The primary sequence alignment shows NuoL, M and N from R. capsulatus Complex I, HycC from an E. coli NiFe-hydrogenase and MrpA and MrpD
antiporters from B. subtilis. Transmembrane helices predicted with the majority vote approach are indicated below the primary sequences, and consecutively
labeled with roman numbers. The stretches of residues where six of eight methods agreed in their prediction of a transmembrane segment are highlighted in
yellow, and areas where five or fewer methods agree are marked in blue. The predicted orientation of the transmembrane segments is indicated with i = inside
and o = outside and is based on analyses of the MrpD polypeptide only (see text). The location of PhoA fusion points in NuoL is indicated with ! and the
corresponding number of the fusion protein. The experimentally determined inside domain between fusion points 10 and 13 is indicated below that predicted.
Consensus sequences (>79% identity) are shown in bold letters for NuoL-, NuoM-, NuoN-, MrpA- and MrpD-type polypeptides. The consensus sequence for
the entire superfamily is shown in red fonts. Two point mutations discussed in the text are indicated with red box.
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O86350, NuoM, accession number O53307, NuoN, acces-
sion number O53308), Nicotina tabacum chloroplasts
(NdhF, accession number P06265, NdhD, accession number
P06262, NdhB, accession number P06256), Synechosystis
sp. strain PCC6803 (accession number sll0026, sll1732,
slr2009, sll0027, sll1733, slr1291, slr12007) and Arabidop-
sis thaliana mitochondria (ND5, accession number P29388,
ND4, accession number CAA69742, ND2, accession num-
ber S71136).
3. Results and discussion
3.1. Predicting the transmembrane topology
The NuoL, NuoM and NuoN polypeptides from R.
capsulatus Complex I, the HycC polypeptide from an E.
coli hydrogenase and the bona fide antiporters MrpA and
MrpD from B. subtilis were used for a detailed analysis,
predicting transmembrane helices using the majority vote
approach recently described by Nilsson et al. [41]. The
polypeptides were individually subjected to eight different
methods predicting transmembrane topology (Fig. 2). When
six or more of the prediction methods agreed on a stretch of
hydrophobic residues, that stretch is shown in yellow,
whereas areas predicted as transmembrane by five or fewer
methods are marked in blue. As seen in Fig. 2, the
antiporters and the different antiporter-like polypeptides
generally contain 14 conserved, predicted transmembrane
helices. In addition, the NuoL, HycC and MrpA polypep-
tides contain a C-terminal extension that is not present in the
NuoM and N polypeptides or in MrpD. In the N-terminal
part, occasional deletions are seen, for instance, the MrpA
from B. subtilis lacks Helix I (Fig. 2), whereas in ND2/
NuoN from Bovis taurus, the first three predicted trans-
membrane segments are absent (not shown). In other MrpA
or NuoN polypeptides, these segments are present. Both the
N-terminal and the C-terminal domains show little primary
sequence similarity compared to the rest of the polypeptide.
Four of the methods, HMMTOP, TMHMM, PHDhtm,
and TMpred, were also used in an attempt to predict the
orientation of the polypeptides. In the most conserved and
central regions, we could get a ‘‘majority vote’’ where three
out of four methods agreed in some of the polypeptides but
not in others and thus the orientation could not be predicted
with confidence. One exception was the MrpD polypeptide,
where the four methods produced a unanimous vote. The
results from the MrpD prediction are indicated below the
primary sequences in Fig. 2.
The overall primary sequence similarity among the
different antiporter and antiporter-like polypeptides can be
as low as 10%, whereas the hydrophobicity analysis dem-
onstrates that the topology of the different polypeptides
nevertheless is conserved. We conclude that the bona fide
antiporter polypeptides and the homologous subunits from
the complex multisubunit enzymes have a common, con-
served structure, in spite of the low absolute primary
sequence similarity.
3.2. Experimental determination of the transmembrane
topology
To experimentally analyze the transmembrane topology,
we used the PhoA fusion protein technique developed by
Manoil and Beckwith [22] and the results from the theoret-
ical transmembrane topology prediction in Section 3.1. The
NuoL polypeptide from R. capsulatus Complex I was used
as a model protein. We chose a minimum number of fusion
points throughout the polypeptide, as described in Ref. [42].
Fusion points (indicated in Fig. 2) were selected at the end
of predicted transmembrane helices, and if present, includ-
ing positively charged residues that could potentially act as
‘‘stop transfer’’ signals [43]. This method has been success-
fully applied to a very large number of membrane proteins,
summarized in Ref. [42], many of which the topology is
either fully or partially confirmed by other methods, cf. Ref.
[44].
An expression plasmid, containing the phoA gene deleted
for the N-terminal signal sequence needed for export of the
gene product, was constructed previously [24]. In this
plasmid, a recognition site for a restriction enzyme generat-
ing blunt ends is used at the upstream end of the truncated
gene, to facilitate in-frame insertion of any gene fragment in
front of the truncated phoA. We subsequently produced
nuoL fragments of different lengths with PCR using Vent
DNA polymerase, that leaves blunt ends. Using this
approach, we observed a low frequency of clones containing
inserted NuoL fragments of apparently correct size, but
containing an extra base pair causing a shift in the following
phoA reading frame. Such clones could, if the resulting
polypeptide was close to the expected size, result in false-
negative fusion proteins. Thus, all plasmid constructs were
isolated and sequenced over the fusion point (not shown).
The fusion proteins were named NLF for NuoL Fusion
protein and numbered consecutively 1–17. The fusion
proteins were expressed in E. coli CC118, a strain from
which the phoA gene has been deleted. PhoA activity in
bacteria expressing fusion protein can be rapidly screened
for on IPTG and X-phosphate-containing plates. Subse-
quently, PhoA activity was assayed directly in permeabi-
lized cells. The results from several independent such
experiments are listed in Table 2. To confirm the presence
of full-length fusion proteins, isolated membranes from E.
coli CC118 expressing the fusion proteins were subjected to
Western blot analyses using anti-PhoA antibodies (Fig. 3).
The constructs are expressed from the lac promotor, leading
to production of some amount of protein before IPTG
addition. In addition to the full-length fusion proteins, small
amounts of proteolytic cleavage products are detected. The
PhoA positive constructs, containing a correctly folded
PhoA domain (43 kDa), are proteolysis resistant and thus
these polypeptides tend to accumulate, whereas the PhoA
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negative constructs are more rapidly degraded. It follows
that it is not meaningful to attempt to quantify and compare
the amounts of fusion protein. In Fig. 3, the total amount of
protein loaded in each lane has been adjusted to clearly
show the individual full-length fusion proteins.
Expression of the three smallest fusion proteins resulted
in cells exhibiting high PhoA activity (Table 2). However,
for NLF1, this most likely represents an artifact, since this
fusion protein contains only a single transmembrane seg-
ment of NuoL. This segment will function as an export
signal sequence for PhoA but will not reflect the true
transmembrane orientation. NLF2 and 3, which contain
positively charged residues before the fusion point, would
in case of misfolding rather have ended up on the inside of
the membrane; therefore, we believe that these fusion
proteins were correctly inserted in the membrane. NLF4 is
the first fusion point that we can assign to the inside of the
membrane. The NLF5 fusion point is probably located in
the middle of Helix V with the result that the PhoA domain
is retained on the outside of the membrane. The following
fusion proteins give unambiguous results (Table 2). The
NLF11 and NLF12 fusion proteins require special mention-
ing. NLF11 results in a PhoA positive phenotype, whereas
NLF12, which contains one additional NuoL amino acid, is
clearly PhoA negative. This amino acid is a lysine, con-
served in NuoL, which was mistakenly excluded by the Vent
polymerase in the isolated NLF11 clone. This illustrates the
extreme importance of positively charged amino acids for
correct folding and membrane insertion of membrane pro-
teins. The following fusion point, NLF13, is located imme-
diately after the most hydrophilic stretch of amino acids in
the polypeptide, and resides on the inside of the membrane.
Taking into account the distinct phenotypes of NLF9,
NLF10, NLF12, NLF13 and NLF14, we conclude that
NLF11 represents a false-positive fusion protein, and that
the entire domain containing the predicted transmembrane
Helix X and XI is in fact not transmembrane, but is located
on the inside of the membrane surface (Fig. 4). Interestingly,
this domain also seems to be of functional importance,
which will be further discussed in a following section. After
the NLF16 fusion point on the outside, the C-terminal
domain which is unique for NuoL, begins. One transmem-
brane segment is followed by a hydrophilic domain residing
on the inside of the membrane. The NLF17 fusion protein
PhoA domain is retained on the inside, but the fusion point
is followed by additional residues that could form a final
transmembrane segment (Fig. 4). In addition, a few of the
prediction methods we used suggested the presence of two
Fig. 3. Western blot of membranes from E. coli CC118 expressing fusion proteins NLF1-17. The lanes containing the corresponding fusion proteins are labeled
1–17, the lane labeled B contains plain E. coli CC118 membranes. The total amount of protein loaded in each lane was: NLF1, 11 Ag; NLF2, 2.6 Ag; NLF3,
3.0 Ag; NLF4, 5.5 Ag; NLF5, 3.6 Ag; NLF6, 10 Ag; NLF7, 3.8 Ag; NLF8, 6.6 Ag; NLF9, 3.0 Ag; NLF10, 6.1 Ag; NLF11, 4.3 Ag; NLF12, 4.5 Ag; NLF13, 5.7





NLF1 294 (n= 6)
NLF2 545 (n= 6)
NLF3 273 (n= 6)
NLF4 122 (n= 8)
NLF5 238 (n= 6)
NLF6 14 (n= 7)
NLF7 331 (n= 6)
NLF8 24 (n= 8)
NLF9 497 (n= 5)
NLF10 26 (n= 6)
NLF11 413 (n= 5)
NLF12 77 (n= 6)
NLF13 52 (n= 8)
NLF14 598 (n= 6)
NLF15 33 (n= 8)
NLF16 539 (n= 5)
NLF17 39 (n= 6)
CC118 2 (n= 2)
a PhoA activity was calculated as in Ref. [25].
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additional transmembrane segments between NLF16 and
NLF17 (Fig. 2). These have been ignored in the topology
model in Fig. 4. It should be noted that the sequence
similarity in this domain is very low, even within NuoL
polypeptides from different species.
3.3. Phylogenetic analysis shed some light on the function
of the polypeptides
The NuoL, M and N subunits of Complex I, the hydro-
genase subunits and the bona fide antiporters may have
arisen from gene duplication at one or several points during
evolution. Thus, the phylogenetic distance relationships of
these proteins rather reflect functional differentiation than
straightforward evolutionary distance. For a comparison, see
Ref. [17], which presents a consensus phylogenetic tree of
the NuoB, C, D, H and I subunits from Complex I and the
Complex I-like enzymes of chloroplasts and archea and the
complex membrane-bound NiFe-hydrogenases, which illus-
trates the evolutionary relationship of these enzymes.
We have analyzed a large set of polypeptide sequences
representing the antiporter-like Complex I polypeptides
from mitochondria (8.3% of the sample) and eubacteria of
distantly related species (29.2%), from NADPH dehydro-
genase from chloroplasts (8.3%) and cyanobacteria (13.9%),
and from F420H2 oxidoreductases from archea (12.5%). The
set also included polypeptides from complex, membrane-
bound NiFe-hydrogenases from both eubacterial and archeal
sources and including enzyme variants containing one, two
or three antiporter-like subunits (9.7%). It should further be
noted that we included only sequences from hydrogenase
enzymes that have been biochemically characterized. As
bona fide antiporters of MrpA- and MrpD-type we used
only those sequences found in the previously described
operon context (13.8%). Finally, the three homologous open
reading frames (ORFs) of unknown function from B. sub-
tilis, V. cholerae and A. aeolicus were included in the
comparison. To access how misalignments in the peripheral
parts, where sequence similarity is low, influence the result,
we used both the entire sequence, and a subset containing
the most conserved region between the fusion points of
NLF10 and NLF14. These analyses gave essentially the
same result (not shown). A simplified version of the
phylogenetic tree, containing a smaller but representative
data set using 28 complete primary sequences, is shown in
Fig. 5. The analyses show that the NuoL/ND5/NdhF/FpoL,
the NuoM/ND4/NdhD/FpoM and the NuoN/ND2/NdhB/
FpoN consistently form distinct clusters. Notably, these
clusters also include the corresponding archeal and chlor-
oplast subunits, although these latter enzymes are not
Complex I. Given the substantial time since the separation
of these organisms, such conservation seems to imply that
the NuoL, M and N subunits have individual and somewhat
different functions within the larger enzyme complex.
The hydrogenase subunits, on the other hand, whether
from enzymes containing one, two or three antiporter-like
polypeptides, are found randomly scattered in the tree. It
thus seems unjustified to label the antiporter-like subunit in
membrane-bound, complex NiFe-hydrogenases ‘‘NuoL’’
[16], and to make NuoL part of the ‘‘hydrogenase module’’
and NuoM and N part of the ‘‘transporter module’’ in
Complex I [4]. However, the results corroborate the con-
clusion of Friedrich and Scheide [17] that the last common
ancestor of F420H2 oxidoreductase of archea and Complex I
of bacteria was a more advanced enzyme than the present-
day membrane-bound hydrogenases.
Deletion of either the MrpA or the MrpD antiporter
encoding gene from B. subtilis resulted in somewhat similar
phenotypes under the conditions tested [11]. In our phylo-
genetic analysis, MrpA and MrpD form individual, distinct
Fig. 4. Transmembrane topology model of NuoL with fusion points indicated. The area between the dotted lines corresponds to the region conserved in all
antiporters of MrpA- and MrpD-type and antiporter-like polypeptides of this superfamily. X indicates location of mutations further discussed in the text.
Helices are numbered consecutively from the prediction in Fig. 2. The domain between fusion points 10 and 13 most likely rests on the membrane surface, or
tilts slightly into the membrane, but is drawn extended for clarity.
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clusters in the tree. This, together with the fact that the two
polypeptides are often encoded by one operon, indicate that
the MrpA and MrpD antiporters may also perform different
functions in vivo, and that it could be worthwhile to analyze
the properties of these B. subtilis deletion strains in greater
detail.
It may also be worth noticing that the NuoL-type and
MrpA-type polypeptides consistently group closer, and the
NuoM-type, NuoN-type and MrpD-type polypeptides form
a second group. It is thus possible that both MrpA- and
MrpD-type polypeptides were ‘‘recruited’’ to a complex
ancestral enzyme, after which a gene duplication of nuoM
to form nuoN or vice versa occurred. An alternative explan-
ation would be convergent evolution. In any case, we can
predict that the function of the NuoL-type antiporter-like
polypeptide may be more closely related to the function of a
MrpA-type antiporter, and that of the NuoM- and NuoN-
type polypeptides to the MrpD-type antiporter.
Finally, the antiporter-like ORFs mentioned in the intro-
duction, found in gene clusters in B. subtilis, V. cholerae and
A. aeolicus adjacent to a gene encoding a large hydrophilic
protein of unknown function, also formed a distinct group in
the phylogenetic tree. Deletion of the gene encoding this
antiporter-like polypeptide from the chromosome of B.
subtilis did not result in a pH- or salt-sensitive phenotype
(Fro¨derberg, Mathiesen and Ha¨gerha¨ll, unpublished data)
corroborating that the function of this protein is different
from that of MrpA and MrpD. It is likely that this polypep-
tide is a subunit in an enzyme with yet unknown function.
3.4. Testing the predictive potential of the phylogenetic tree
Synechosystis sp. strain PCC6803 contains a NADPH
dehydrogenase similar to that in chloroplasts, composed of
11 subunits corresponding to Complex I subunits, but
lacking the NuoE, NuoF and NuoG equivalent subunits
[45]. In this organism, the genes are not organized in distinct
operons but the sequence of the whole genome has been
determined. Most of the NADPH dehydrogenase encoding
genes occur in one copy, but there are genes encoding 10
different antiporter-like polypeptides in the genome. These
have been assigned as three NdhF (corresponding to NuoL),
six NdhD (corresponding to NuoM) and one NdhB (corre-
sponding to NuoN). In a recent study, the six NdhD
encoding genes were deleted from the genome, and the
properties of the deletion strains were compared. It was
Fig. 5. Unrooted phylogenic tree created by Prodist with bootstrap and 100 replicates. The tree includes: bona fide antiporters from B. subtilis (MrpA Bs,
accession number BG12355, MprD Bs, accession number BG12345), B. halodurans (ShaA Bh, accession number BH1319, ShaD Bh, accession number
BH1316) and R. meliloti (PhaA Rm, accession number Q52978, PhaD Rm, accession number Q52981); NiFe-hydrogenase subunits from enzymes expressed
from operons with one gene encoding an antiporter-like polypeptide E. coli (HycC Ec accession number P16429) and Methanosarcina barkeri (EchA Mb,
accession number O59652), from an operon containing two antiporter-like equivalents exemplified by Rhodospirillum rubrum (CooM Rr, accession number
U65510) and three antiporter encoding genes as in E. coli (HyfB Ec, accession number P23482, HyfD Ec, accession number P77416, HyfF Ec, accession
number P77437); F420H2 oxidoreductase subunits from Archeoglobus fulgidus (FpoL Af, accession number O28449, FpoM Af, accession number O28450,
FpoN Af accession number AF1827) and Methanosarcina mazei (FpoL Mm, accession number Q9P9F5, FpoM Mm, accession number Q9P9F4, FpoN Mm,
accession number Q9P9F3); NADPH dehydrogenase subunits from Oryza sativa chloroplasts (NdhF Os, accession number P12129, NdhD Os, accession
number P12127, NdhB Os accession number P12125) and Complex I subunits from R. capsulatus (NuoL Rc, accession number P50939, NuoM Rc, accession
number P50974, NuoN Rc, accession number P50973) and from B. taurus mitochondria (ND5 Bt, accession number P03920, ND4 Bt, accession number
P03910, ND2 Bt, accession number P03892). Finally, the ORFs from B. subtilis (Orf Bs, accession number BG10949), V. cholerae (Orf Vc, accession number
VC1581) and A. aeolicus (Orf Aa, accession number AA0690) that are found adjacent to a conserved polypeptide of unknown function are included. Simple
distance (with no corrections) expressed as observed number of substitutions per 100 amino acids in this data set ranges from 42.58 to 88.22.
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concluded that at least two functionally distinct NADPH
dehydrogenases can be made in Synechosystis, by varying
the composition of antiporter-like polypeptides in the
enzyme [46]. We included the 10 primary sequences of
antiporter-like polypeptides from Synechosystis in our full
set of antiporter-like sequences, and repeated the analyses.
Three polypeptides (sll0026, sll1732 and slr0844) group
with NuoL, one polypeptide (sll0223) groups with NuoN
but only four polypeptides (slr0331, slr1291, sll0027 and
sll1733) end up in the NuoM cluster. The remaining two
polypeptides (slr2007 and slr2009) instead form a subgroup
close to antiporters of MrpD type. Interestingly, deletion of
these corresponding genes did not result in any significant
differences from wild type under the conditions tested,
except that the deletion strains grew slower under acidic
conditions [46]. We thus suggest that slr2007 and slr2009
are not NADPH dehydrogenase subunits, but rather anti-
porters of MrpD type.
3.5. Consensus sequences in the transmembrane topology
model
We have derived a consensus sequence for all the poly-
peptides in the family, and consensus sequences for each of
the polypeptide subfamilies that form distinct clusters in the
phylogenetic tree. The same set of primary sequence was
used, except that two additional sequences of antiporters were
included. These were Bacillus firmus MrpA (AAF21812)
and MrpD (AAF21815) and Deinococcus radiodurans
AAF10453 and G75389. The minimal number of votes re-
quired for a consensus was set such that it became as close
to 80% identity as possible in each group (NuoL 79%,
NuoM 79%, NuoN 79%, MrpA 86%, MrpD 86%). The
consensus sequences obtained for each of the groups are
marked in bold type in the respective primary sequences in
Fig. 2. The group containing the ORFs of unknown function
was left out, since only three sequences are available. The
residues that are identical in 79% of the entire set of
analyzed polypeptides are likewise marked in red in Fig.
2. For the NiFe-hydrogenase subunits, which do not form a
phylogenetic cluster, a consensus sequence would corre-
spond roughly to residues marked in red.
The general and the individual consensus sequences can
now be related to the common topology model (Fig. 4).
Toward the outside of the membrane, we find an aspartate at
the beginning of Helix III and a glutamate at the beginning
of Helix V in the consensus sequence of all antiporters and
antiporter-like polypeptides. A motif toward the end of
Helix XII is also conserved. Facing the inside of the
membrane, conserved residues are more abundant. Since
this consensus sequence describes the full set of sequences
including the bona fide antiporters, the bias in similarity
toward the inside cannot be related to the interaction with
other conserved subunits in the enzymes, which are located
on the inside interface of the membrane (Fig. 1). The loop
region between Helix VII and VIII contains several gen-
erally conserved residues. Amino acid residues in this
domain of NuoM in E. coli Complex I was recently labeled
with an azidoquinone [47] implying the presence of a
quinone binding site. The previously discussed large inside
domain between Helices IX and XII also contains many
residues that are fully conserved (Fig. 2). We attempted to
predict the secondary structure of this domain using several
algorithms and methods, but obtained very poor agreement
between predictions (not shown). In the predicted Helix XI,
the consensus sequence motif in the NuoL group and the
MrpA group implies the presence of a helical moment,
which would result in an amphipathic helix with a con-
served face and a hydrophobic face, but there is no such
tendency in the other groups. There is no actual sequence
similarity between the MrpA antiporter and the K+ channel
[48], but the image of two short helices tipping somewhat
into the membrane resembles the structural elements of the
ion collector and selectivity filter of the latter protein. As
previously mentioned, the functional mechanism of this type
of antiporter/antiporter-like polypeptide is unknown on the
molecular level. Yet, two amino acid residues located within
or adjacent to the inside domain are known to be important
for function in the superfamily. In mammalian Complex I,
the NuoL, M and N subunits are mitochondrially encoded.
The first mutation known to affect function is found in 50%
of patients suffering from Leber’s hereditary optic neuro-
pathy. In transmitochondrial cybrids carrying the ND4-
11778 mutation, the maximal respiratory rate was decreased
by 30–36% [49]. The same point mutation (NuoM R368H)
has been introduced in R. capsulatus NuoM to mimic the
disease by Lunardi et al. [50]. In R. capsulatus, the mutation
affected growth under conditions that require a functional
Complex I, but had little effect on assays performed with
isolated membranes. The second known mutation is a point
mutation (G393R) in the MrpA-type antiporter that caused an
alkali-sensitive phenotype in B. halodurans C-125, which
led to the first description of an antiporter of this type [8].
The position of these point mutations is indicated with a red
square in Fig. 2, and with X in the topology model in Fig. 4.
A recent paper [51] attempts to identify residues respon-
sible for Na+ translocation by comparing NuoL from E. coli
and Klebsiella pneumoniae Complex I, with MrpA on one
hand and NuoL from other Complex I enzymes on the other
hand. Unfortunately, few sequences are included in the
comparison, and the sequence identity between E. coli and
K. pneumoniae, the only two Complex I known to trans-
locate Na+, is very high, which hampers the analyses. Tyr139
and Tyr263 are listed as prime candidates for ligating Na+.
As seen in Fig. 2, these residues are not included in the
consensus sequence of a larger set of MrpA sequences. Y139
is located in the beginning of Helix Vand Y263 in the end of
Helix VIII, that is, in the topology model, both residues are
located on the outside of the membrane (Fig. 4).
The coupling mechanism of Complex I is unknown, but
H+ pumping was in fact observed in the presence of a
specific quinone binding site inhibitor [1]. This may imply
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that Complex I is a chimera of a redox-driven and a
conformation-driven proton pump [4]. Complex I is capable
of both NADH oxidation coupled to H+ pumping and DAH+ -
supported NAD+ reduction, demonstrating that the coupling
mechanism must be reversible. At least some, but perhaps
all, Complex I are capable of translocating Na+ [18,19]. In
case of the membrane-bound NiFe-hydrogenases, one may
speculate that the antiporter-like polypeptide(s) was
recruited to provide a transmembrane H+ channel for H2
production. An important issue to understand the coupling
mechanism is thus whether the antiporter-like polypeptides
in the complex enzymes are merely providing channels for
one ion species, or if a counter-ion is involved in the
reaction. Our topology model and primary sequence analy-
sis of the superfamily of antiporter-like polypeptides pro-
vide a basis for addressing these questions.
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